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Abstract. The increasing interest for phytochemical antioxidants, found in many medicinal 
plants, is demonstrated experimentally by epidemiological and in vitro studies which show their 
positive effects on human health. Mistletoe contains therapeutically active ingredients which incubated 
with several human cancer cell lines revealed cytotoxicity for the cancer cells, but  no evidence is 
available for their chemoprotective properties. We investigated in vitro the potential of extracts from 
Viscum album growing on Mallus domestica (VAM) to modulate the activity of phase II detoxifying 
enzymes using the gluthatione S-transferase (GST) and quinone oxidoreductase (QR) assays and to 
inhibition of adherent epithelial human ovarian tumor cells A2780 proliferation using the MTT assay. 
We found that different concentrations of VaM extract had inhibitory effects on the growth of adherent 
epithelial human ovarian tumor cells A2780 (IC50 = 120.62 µg/ml, after 48 h treatment). Also, this 
extract is a good antioxidant source (total phenol content of 91.51 mg gallic acid equivalents /g dry 
weight), having a radical scavenging ability and a reducing potential proportional to the dose used 
(from 0.312 to 5 mg/ml) in vitro. At 120 µg/ml, this extract increased, significantly, the activity of 
GST and QR, as well the level of GSH. 
 
Keywords: Viscum album, gluthatione S-transferase (GST), quinone oxidoreductase (QR), 
DPPH, FRAP, MTT. 
 
INTRODUCTION 
 
Viscum album is a medicinal plant used for many years as a traditional remedy in 
preventive medicine and in complementary cancer therapies. European mistletoe (Viscum 
album L.) is an evergreen, semiparasitic plant, normally found growing on a variety of trees, 
especially pine, poplar, apple trees, locus trees etc. The phytochemical profile of mistletoe 
depends on the host trees of this plant (Vicas et al., 2011, Luczkiewicz et al., 2001). The main 
bioactive compounds found in mistletoe are lectins (glycoproteins with effects on cell-
proliferation) and viscotoxin (a small protein molecule of 5 kDa) (Edlund et al., 2000; 
Romagnoli et al., 2000). Alkaloid concentration is usually low, and dependent on the host tree 
type (Peng et al., 2005). It is considered that, flavonols like quercetin, kampherol and their 
methyl derivatives, and flavonone, naringenin are the antioxidant compounds in mistletoe 
(Haas et al., 2003). Among the phenolic acids presents in mistletoe, digallic and o-coumaric 
acid in the free or glycosilated forms (Luczkiewicz et al., 2001) are also considered to be 
compounds with antioxidant activity.  
The human body is exposed to a various xenobiotics in one’s life, from food 
components to environmental toxins to pharmaceuticals, and has developed complex 
enzymatic mechanisms to detoxify these substances.  
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The non-reactive compounds (xenobiotics) could be biotransformed in two phases: 
functionalization, which use oxygen to form a reactive site and conjugation, which results in 
addition of a water-soluble group to the reactive site. These two steps, functionalization and 
conjugation, are termed Phase I and Phase II detoxification, respectively. The result is the 
biotransformation of a lipophilic compound, not able to be excreted in urine, to a water 
soluble compound able to be removed in urine. Therefore, detoxification is not one reaction, 
but rather a process that involves multiple reactions and multiple players (Fig. 1). 
A major protective mechanism against oxidizing substances capable of damaging 
DNA integrity and initiating carcinogenesis is the induction of phase II detoxification and 
antioxidant enzymes by chemopreventive agents.  
The families of enzymes induced by chemopreventive agents have been classified into several 
categories (Giudice and Montella, 2006): 
- transferases (GSTs), UDP-glucuronosyltransferases (UDP-GTs), NAD(P)H:quinine 
oxidoreductase 1 (NQO1), epoxidehydrolase (EH), aflotoxin B1, aldehyde reductase (AFAR), 
heme oxygenase 1 (HO-1), ferritin) 
- antioxidants and their modulating enzymes (gamma-glutamylcysteine synthetase (-
GCS), superoxide dismutase (SOD), catalase (CAT), gluthathione reductase (GR), 
thioredoxin reductase (TR), peroxiredoxins (Prxs), gluthathione S-conjugate efflux pumps, 
nicotinamide adenine dinucleotide phosphate (NADPH) and cofactors-generating enzymes) 
- molecular chaperones/proteasome systems 
- DNA repair enzymes 
- Anti-inflammatory response proteins (HO-1, ferritin, leucokotriene B4 dehydrogenase) 
 
Fig. 1. The phase I- and phase II- enzyme systems and their relevance for detoxification. 
 
One of the most promising areas in cancer research is chemoprevention. The induction 
of phase II enzymes, such as glutathione S-transferase (GST) and quinone reductase (QR) is 
considered a major mechanism of protection against the initiation of carcinogenesis and 
chemical stress. GSTs are ubiquitous multifunctional enzymes, which play a key role in 
cellular detoxification and catalyzes the conjugation of electrophilic compounds with 
glutathione, resulting in the products more water-soluble that are generally more hydrophilic 
and less cytotoxic, that are metabolized further to mercapturic acid and then excreted. GSTs 
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are only part of a complex detoxification system because multiple enzymes are involved in the 
redox cycling of GSH.QR functions as an inducible protective device against quinone toxicity 
by reducing quinones to relatively stable hydroquinones. These resulting hydroquinones can 
be conjugated and excreted through mercapturic acid pathways.The aim of our work is to 
investigate the in vitro potential of an extract obtained specifically from Viscum album 
growing on Mallus domestica (VaM) and its ability  to induce phase II detoxifying enzymes. 
The gluthatione S-transferase (GST) and quinone oxidoreductase (QR) assays as well the 
inhibition of adherent epithelial human ovarian tumor cells A2780 proliferation using 3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay were applied.  
 
MATERIALS AND METHODS 
 
Misletoe samples and phenolic compounds  extraction 
The leaves and stems of V. album, were harvested from Malus domestica (VaM) in 
February 2010 on the North-West of Romania country (Borod – Gheghie region). The dried 
leaves and stems were kept for 3 days, at 600C, grounded and stored in sealed plastic bag until 
the subsequent analysis. The dried material was treated with chloroform (1:4, g/v) for 24 
hours in order to remove lipophilic compunds. After removal of chloroform, phenolic acids 
were extracted with 70% ethanol solution added to a final volum ten fold higher than sample 
weight, at room temperature, in the dark, for 24h. Ethanol was removed using a IKA 
Distilling Rotary Evaporator and then, the aqueous extract was freezed and liophylized with a 
Laboratory Freeze-Dryer Martin Christ. For the determination of antioxidant activity, 
liophylized extract was dissolved in methanol at different concentration (0.5 mg/ml, 0.25 
mg/ml, 0.125 mg/ml, 0.062 mg/ml and 0.031 mg/ml). 
Determination of antioxidant activities 
The 2,2-diphenyl-1-picrylhydrazyl (DPPH) radical-scavenging activity was 
determined using the method proposed by Brand-Williams et al., (1995). Briefly, a volume of 
150 µl mistletoe extract at different concentration (between 0.031 to 0.5 mg/ml) and 1400 l 
DPPH methanolic solution (80 µM) were added and the decrease in the absorbance of the 
resulting solution was monitored at 515 nm after 30 min. The percentage of scavenging effect 
of mistletoe extract against DPPH radicals, was calculated using the following equation: 
 
DPPH scavenging effect (% ) = [(A0 - A s) x 100 ] / A0 
 
Where, A0 is absorbance of the blank, and AS is absorbance of the samples at 515 nm. 
As positive antioxidant control we used Trolox (the concentration between 50 and 500 M), 
and also, the results were expressed as mol Trolox per 1 g of extract’s dry weight. The 
discoloration of DPPH was plotted against the sample concentration in order to calculate the 
IC50 value, which is the amount of sample necessary to decrease the absorbance of DPPH by 
50%. 
The Ferric reducing antioxidant power (FRAP) assay was applied according to the 
method of Benzie and Strain (1996) with some modifications. The FRAP assay consists in the 
ferric tripyridyltriazine (Fe(III)-TPTZ) complex  reduction to the ferrous tripyridyltriazine 
(Fe(II)-TPTZ) by an antioxidant at low pH. The stock solutions included: 300 mM acetate 
buffer; 270 mg FeCl3 · 6 H2O dissolved in 50 ml distillated water; 150 mg TPTZ and 150 µl 
HCl, dissolved in 50 ml distillated water. The working FRAP solution was freshly prepared 
by mixing 50 ml acetate buffer, 5 ml FeCl3 · 6 H2O solution and 5 ml TPTZ solution. 
Mistletoe extracts (100 µl) were allow to react with 500 l FRAP solution and 2 ml distilled 
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water, for 1 h, in dark. The final colored product (ferrous tripyridyltriazine complex) was 
quantified by VIS absorption at 595 nm, and IC50 of VaM was calculated. As positive 
antioxidant control we used Trolox and obtained a standard linear curve, between 50 and 500 
mol/l Trolox. The FRAP value was obtained using the following equation based on the 
calibration curve: y=0.0157 x + 0.0549 (R2=0.9981), where x was the absorbance and y was 
the mol Trolox equivalent.  
Determination of total phenolics  
The total phenolic content was determined by the Folin-Ciocalteu method (Singleton et al., 
1999). Mistletoe extract (100 µl) was mixed with 1750 µl distillated water, 200 µl Folin-
Ciocalteu reagent (dilution 1:10, v/v) and 1000 µl of 15% Na2CO3 solution, and the mixture 
incubated at room temperature, in the dark, for 2 hours. The absorbance was measured at 765 
nm using a spectrophotometer Schimadzu mini UV-Vis. The calibration curve was linear for 
the range of concentrations between 0.1-0.5 mg/ml gallic acid. Total phenolic content of 
mistletoe extract was expressed as mg gallic acid equivalents (GAE)/g dry weight, using the 
following equation based on the calibration curve: y=1.9735x + 0,0261 (R2=0.9928), where x 
was the absorbance and y was the gallic acid equivalent (mg/ml).  
Cell culture  
Adherent epithelial human ovarian tumor cells A2780 were maintained in RPMI 
medium supplemented with 10% fetal serum, at 37C, 5% CO2, 90% humidity. For 
proliferation  A2780, 1  x 104 cells/well were seeded in 96 well plates. For other experiments 
cells were seeded in 6 well plates 5 x 105 cells/well. After reaching 90% confluence, the 
growth medium was removed and replaced with fresh medium for untreated cells or with 
medium containing mistletoe extract for treated cells. 
To evaluate the respiration capacity and viability of cells,  we aplied the MTT assay. 
Cells were incubated for 24, 48 and 72 hours with different concentrations (0, 10, 20, 40, 80 
and 160 g/ml) of mistletoe extract (VaM). The tetrazolium salt was used for assaying the 
quantification of living metabolically active cells. 200 µl MTT solution (3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide)(MTT) in HBSS buffer were added to 
each well. MTT reagent is metabolized by mitochondrial dehydrogenase to formazan. After 2 
h of incubation the MTT reagent was removed and the formazan particles were solubilized 
with 200 µl DMSO. The end-product was measured at 550 nm with a microplate plate reader 
HT BioTek Synergy (BioTek Instruments, USA). Viability was expressed as the percentage of 
actively proliferative cells. 
Determination of phase II enzymes in A2780 cells 
GST assay. The activity of gluthatione S-Transferase from human ovarian tumor cells A2780, 
after exposure at different concentration of VaM extract was measured with  the Cayman 
Chemical Glutathione S-Transferase Assay Kit. The principle of assay consist in the 
measuring the conjugation of 1-chloro-2,4-dinitrobenzene (CDNB) with reduced glutathione. 
The conjugation is accompanied by an increase in absorbance at 340 nm. The rate of increase 
is directly proportional to the GST activity in the sample. 
QR assay. The activity of quinone reductase was measured according to Lind at al. (1990). 
The activity of quinone reductase was determined using NADP+/menadione as substrates. The 
spectrophotometric assays were based on absorption at 550 nm and all samples were 
measured in triplicate. One unit of enzyme activity is defined as the amount of enzyme 
catalyzing the conversion of 1µmol of substrate to product per minute at 370C. The activity of 
QR was expressed as U/mg protein. 
 486 
Glutathione assay. The GSH assay was performed using an optimized enzymatic recycling 
method with glutathione reductase (Sigma, St. Louis, USA). Results are expressed as nmoles 
GSH/mg protein in cell pellet. 
Protein determination for enzymes assay. The cells were centrifuged at 1000 rpm, the PBS 
was removed and the pellet was homogenized in phosphate buffer 100 mM, containing 2mM 
EDTA. Then the homogenate was centrifuged at 10000 rpm, for 15 minutes. The supernatant 
was used to determine protein concentration using the bicinchoninic acid assay kit instructions 
(Sigma, St. Louis, USA). 
 
RESULTS AND DISCUSSION 
 
 Antioxidant  activity 
Antioxidant properties of mistletoe extracts that are growing on Malus domestica were 
determined by two methods, DPPH and FRAP (Tab.1 and 2) 
Table 1 include data which show the scavenging effect  of different concentrations of VaM 
extract, as determined by DPPH assay, measured as percentage of inhibition (%), as Trolox 
eauivalents. The IC50 value, expressed as percentage, which represent the quantity of VaM 
extract which decrease by 50% the absorbance of DPPH, is also shown. We found  a dose-
dependent antioxidant activity of this extract, higher than  Trolox equivalent at 2.5 and 5 
mg/ml. The IC50 value was low ( 102.54 g/ml ) demontrating that this extract was powerful 
antioxidant. 
Tab. 1 
 
The scavenging effect  of different concentrations of VaM extract, as determined by DPPH assay, measured as 
percentage of inhibition (%), as Trolox eauivalents and as IC50 values.  
 
Concentration of VaM 
extract 
(mg/ml) 
% DPPH mol Trolox/g dry 
weight 
IC50 
(g/ml) 
5 26.97 1.58 ± 0.001 
2.5 18.49 1.02 ± 0.019 
1.250 9.67 0.44 ± 0.039 
0.625 8.82 0.28 ± 0.001 
0.312 7.21 0.38 ± 0.018 
 
 
102.54 
TROLOX  - - 0.13 
 
Other authors (Oluwaseun and Ganiyu, 2008) who investigated the antioxidant properties 
of methanol extracts of V. album isolated from cocoa and cashew trees in the South Western 
part of Nigeria, found the scavenging ability of methanol extracts to be dose-dependent (0-10 
mg/ml). The free radical scavenging ability of the V. album extract from cocoa tree performs 
better than that from cashew tree, a fact that is in agreement with the total phenol content of 
the two extracts (182 mg /100 g, and 160 mg /100 g, respectively). 
By FRAP assay it was measured  the antioxidant, reducing potential of the VaM extract 
reacting with a ferric tripyridyltriazine (Fe3+–TPTZ) complex and producing a colored 
complex of ferrous tripyridyltriazine (Fe2+–TPTZ). The antioxidant capacity was expressed in 
mol Trolox/g dry weight and were significantly dependent on the extract doses, as shown in 
Tab. 2. 
Tab. 2 
 
The antioxidant capacity of VaM, measured by FRAP assay. The values  are expressed in mol Trolox/g dry 
weight. 
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Concentration of VaM extract 
(mg/ml) 
mol Trolox/g dry weight 
5 1962.02 ± 0.002 
2.5 1048.28 ± 0.001 
1.250 566.11 ± 0.000 
0.625 313.11 ± 0.005 
0.312 155.37 ± 0.000 
 
Vicas et al., 2009, investigated by the same FRAP assay the antioxidant capacity of  
aqueous extracts of fresh leaves and stems from V. album. There were noticed differences 
between the antioxidant activity of mistletoe extract from leaves and stems. Among the 
selected plants, crude aqueous extract of V. album leaves grown on Mallus domestica 
exhibited the highest antioxidant activity.  
Phenolic compounds are known to have antioxidant activity and their activity is due to 
their redox properties, which play an important role in neutralizing free radicals, quenching 
singlet and triplet oxygen, or decomposing peroxides (Zheng and Wang, 2001, Bhoyar et al., 
2011). Phenolic content in the mistletoe extract, as determined by Folin-Ciocâlteu method  
was 91.51 mg gallic acid equivalents /g dry weight. Acoording to HPLC analysis of mistletoe 
hosted by Mallus domestica (VaM), Vicas et al., 2011 identified seven phenolic acids in 
leaves, ferulic acid being the main compound in leaves and stems (7.81 µg/g dry matter, and 
6.88 µg/g dry matter, respectively) of VaM samples. 
Antiproliferative effect on cells A2780 by mistletoe extract 
The anti-proliferative effects of VaM extract on A2780 cells were investigated using 
MTT assay. The results obtained are presented in the Fig.2. The A2780 cell viability was 
inhibited to 25.51% and 63.47 % by 160 g/ml mistletoe extract treatment after 24 hours 
respectively, 48 hours. The IC50 (50% inhibitory concentration) was obtained for 261.70 
µg/ml, 120.62 µg/ml and 120.10 µg/ml extract concentration after 24 hours, 48 hours, 
respectively 72 hours, as presented in Table 3.  
 
 
 
 
 
 
 
 
 
 
 
Fig.2. The antiproliferative effects of VaM extract on A2780 cells, at different concentrations, using the MTT 
assay. 
Tab. 3 
The IC 50 of  VaM extract on A2780 cells at different time of exposure 
 
IC 50 (g/ml) 
24 hours 48 hours 72 hours 
 
VaM 
261.70 120.62 120.10 
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Recently, the cytotoxic and apoptosis-inducing effects of an aqueous mistletoe extract 
dose-dependent in leukemic Jurkat cells were reported. The IC50 of mistletoe extract on Jurkat 
cells was 35.67 g/mL (Sabová et al., 2010). Sadeghi-Aliabadi et al., 2006, evaluated the 
cytotoxic effects of Iranian mistletoe extracts (growing on Carpinus betulus) on the following 
cancer cell lines: Hela, KB, MDA-MB-468, K562 and MCF using colorimetric MTT assay. 
Their results showed that plant juice was the most cytotoxic fraction on all cancer cells tested 
(IC50=0.0316 mg). The IC50 of hydroalcoholic and methanolic extracts were 0.1 and 0.316 
mg, respectively. Rugina et al., 2010, used A2780 cells for treatment with mistletoe extract 
for 24 h and assayed for cell viability. A2780 cell viability was inhibited to 87% by 50 g/ml 
mistletoe extract treatment, and to 79% at 110 g/ml extract concentration. Cytotoxic 
concentration of 200 g/ml of mistletoe extract reduced A2780 cell viability with 60%. The 
IC50 (50% inhibitory concentration) was obtained for 170 µg/ml extract concentration. 
Hashimoto et al., 2007, investigated the anti-cancer mechanism of benalu  extract (a parasitic 
plant to tea and coffee plants) on human leukemia Jurkat T cell. The treatment with the extract 
inhibited the cell proliferation in a dose and time dependent manner. 
Induction on phase II enzymes 
The modulation of phase II enzymes by the different extracts or drugs can be study both, in 
vitro, using different cell lines, or in vivo, used animal experiment. In vitro, the following  cell 
lines were used: mouse liver cells (Hepa-1c1c7) (Bolling et al., 2007; Awika et al., 2009; 
Yang and Liu, 2009), human hepatoma (HepG2) (Brandon et al., 2006; Westerink and 
Schoonen, 2007; Syng-ai et al., 2011), ovarian carcinoma (IGROV-1) (Brandon et al., 2006), 
colon carcinoma (CaCo-2, LS180) cell lines(Brandon et al., 2006), Human breast tumor cell 
lines, MDAMB  and MCF-7 cells (Syng-ai et al., 2004), rat hepatocytes (Syng-ai et al., 2004)  
The effect of VaM extract on the GST and QR activities in adherent epithelial human 
ovarian tumor cells A2780 was analyzed. GST activity in control (the cells without of 
treatment with mistletoe) was 6.98 ± 0.17 nmol/min/mg protein (Fig.3 A).  
A slight increase of GST activity (7.42 ± 0.17 nmol/min/mg protein) was observed 
after 48 h of treatment with 60 g/ml VaM extract compared to untreated cells. Instead, the 
extract concentration of 120 g/ml, increased the GST activity to 9.66 ± 0.20 nmol/min/mg 
protein. Interestingly, a higher amount of extract (240 g/ml) induced an inhibitory effect on 
GST enzyme activity (6.50 nmol/min/mg protein).  
The QR activity of untreated A2780 cells was 0.88 ± 0.56 U/mg protein. Administration of 60 
g/ml of VaM extract induced a drastic decrease of QR activity (0.43 ± 0.39 U/mg protein), 
but for the other two extract concentrations tested (120 and 240  g/ml) resulted an increase of 
enzyme activity (1.35 ± 0.00, respectively 1.01 ± 0.41 U/mg protein) (Fig.3 B).  
In addition, we determined the level of GSH in human ovarian tumor cells without and 
with the treatment with mistletoe extract. The highest concentration of VaM extract (240 
g/ml) increased the level of GSH (65.98 ± 0.353 nmol GST/mg protein) compared to 
untreated cells (Fig.3C).Yang and Liu, 2009, shown that the phytochemicals present in grapes 
(especially the grape variety Cabernet Franc) have potent QR induction (CD = 0.6 ± 0.1 
mg/ml) and antiproliferative activity toward Hepa1c1c7 cells (EC50 = 8.7 ± 2.4 mg/ml). 
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Fig. 3. The effects of VaM extracts on GST activity (A), QR activity (B) and the level of GSH in adherent 
epithelial human ovarian tumor cells A2780. Data shown are mean values, with bars indicating the SD of the 
mean (n = 3) 
Treatment of Hepa 1c1c7 cells with medicinal plant Thunbergia laurifolia Lindl. 
(Acanthaceae)extracts resulted in a dose-dependent increase in QR specif c activity for all 
extracts. Acetone extract (92 g GAE/mL) increased QR activity 2.8-fold, while ethanol (120 
g GAE/mL) and water (1000 g GAE/mL) extracts increased QR activity by 1.35- and 1.56-
fold, respectively (Oonsivilai et al., 2007).  
 
CONCLUSION 
 
We show that different concentrations of  an extract from mistletoe growing on Mallus 
domestica had inhibitory effects on the growth of adherent epithelial human ovarian tumor 
cells A2780 (IC50 = 120.62 µg/ml, after 48 h treatment). Also, this extract is a good 
antioxidant source (total phenol content of 91.51 mg gallic acid equivalents /g dry weight), 
having a radical scavenging ability and a reducing potential proportional to the dose used 
(from 0.312 to 5 mg/ml) in vitro. At 120 µg/ml, this extract increased, significantly, the 
activity of GST and QR, as well the level of GSH.Further studies are needed to demonstrate 
the specific induction of phase II detoxifying enzymes activity by mistletoe extract, using 
different in vitro cell models. 
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